Clinical interests in prostate, lung, and skin cancers, plus benign conditions and lymphoma.
David was actively involved with the introduction of a number of technological advances in radiation therapy at Frankston, to support the treatment of a number of tumour streams.
David has overseen the introduction of a number of technological advances in radiotherapy delivery at Frankston, including intensity modulated and image guided radiotherapy for prostate and other cancers, deep inspiration breath hold radiation therapy for breast cancer, and stereotactic brain and body radiotherapy.
The role of radiotherapy in benign disease (particularly Dupuytren’s disease of the hands).
- Fellow, RANZCR
- Member, ASTRO
- Member, ESTRO